A detailed history of Ascent Group, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Ascent Group, LLC holds 45,931 shares of MRK stock, worth $4.59 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares
45,931
Previous 47,752 3.81%
Holding current value
$4.59 Million
Previous $5.91 Million 11.77%
% of portfolio
0.4%
Previous 0.49%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$111.15 - $128.97 $202,404 - $234,854
-1,821 Reduced 3.81%
45,931 $5.22 Million
Q2 2024

Aug 14, 2024

SELL
$123.8 - $132.96 $454,346 - $487,963
-3,670 Reduced 7.14%
47,752 $5.91 Million
Q1 2024

May 15, 2024

BUY
$113.24 - $131.95 $1.7 Million - $1.98 Million
14,974 Added 41.08%
51,422 $6.79 Million
Q4 2023

Feb 13, 2024

BUY
$100.18 - $109.02 $41,574 - $45,243
415 Added 1.15%
36,448 $3.97 Million
Q3 2023

Nov 14, 2023

BUY
$102.95 - $114.33 $295,466 - $328,127
2,870 Added 8.65%
36,033 $3.71 Million
Q2 2023

Aug 14, 2023

SELL
$108.61 - $118.38 $1.11 Million - $1.21 Million
-10,182 Reduced 23.49%
33,163 $3.83 Million
Q1 2023

May 10, 2023

SELL
$102.94 - $114.86 $903,813 - $1.01 Million
-8,780 Reduced 16.84%
43,345 $4.61 Million
Q4 2022

Feb 16, 2023

BUY
$87.44 - $112.11 $86,478 - $110,876
989 Added 1.93%
52,125 $5.78 Million
Q3 2022

Nov 14, 2022

BUY
$84.53 - $94.96 $517,577 - $581,440
6,123 Added 13.6%
51,136 $5.18 Million
Q2 2022

Aug 05, 2022

BUY
$83.49 - $94.64 $515,717 - $584,591
6,177 Added 15.91%
45,013 $4.02 Million
Q1 2022

May 10, 2022

BUY
$73.51 - $82.4 $105,339 - $118,079
1,433 Added 3.83%
38,836 $3.19 Million
Q4 2021

Mar 01, 2022

BUY
$72.28 - $90.54 $2.7 Million - $3.39 Million
37,403 New
37,403 $2.99 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $253B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Ascent Group, LLC Portfolio

Follow Ascent Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ascent Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ascent Group, LLC with notifications on news.